Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1 1

Status

Completed 4Terminated 1

Sponsor Class

OTHER 5NIH 4NETWORK 2

Study Type

Interventional 5

Sponsor

Cancer Type

Breast 5

Conditions

Lymphoma 142Leukemia 111Leukemia, Myeloid, Acute 100Precursor Cell Lymphoblastic Leukemia-Lymphoma 93Lymphoma, Non-Hodgkin 91Multiple Myeloma 88Lymphoma, Large B-Cell, Diffuse 80Myelodysplastic Syndromes 74Lymphoma, Follicular 73Lymphoma, Mantle-Cell 72Leukemia, Lymphocytic, Chronic, B-Cell 69Burkitt Lymphoma 67Hodgkin Disease 66Lymphoma, Large-Cell, Immunoblastic 60Lymphoma, B-Cell, Marginal Zone 49Breast Neoplasms 48Neoplasms, Plasma Cell 39Leukemia, Myeloid, Accelerated Phase 34Leukemia, Myeloid, Chronic-Phase 33Recurrence 32Myeloproliferative Disorders 32Ovarian Neoplasms 31Congenital Abnormalities 30Blast Crisis 30Sarcoma 28Dendritic Cell Sarcoma, Interdigitating 28Central Nervous System Neoplasms 28Leukemia, Myelomonocytic, Chronic 27Neuroblastoma 25Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 21

Interventions

Cyclophosphamide 23Paclitaxel 19Epirubicin 14Doxorubicin 13Carboplatin 13Trastuzumab 12Docetaxel 10Taxes 9Albumin-Bound Paclitaxel 7pembrolizumab 5Radiotherapy 5Fluorouracil 5Filgrastim 5Bevacizumab 5130-nm albumin-bound paclitaxel 5pertuzumab 4Neoadjuvant Therapy 4Cisplatin 4eribulin 3Thiotepa 3Tamoxifen 3Panitumumab 3Melphalan 3Magnetic Resonance Spectroscopy 3Flow Cytometry 3Capecitabine 3Biopsy 3sargramostim 2Specimen Handling 2Peripheral Blood Stem Cell Transplantation 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
OTHER × Inflammatory Breast Neoplasms × Filgrastim × Clear all
NCT00003042 2026-02-20

Chemotherapy and Stem Cell Transplantation in Treating Patients With Stage IIIB Breast Cancer

City of Hope Medical Center

Phase 2 Completed
41 enrolled 9 charts
Breast

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00513695 2019-08-07

Sunitinib Malate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide Before Surgery in Treating Patients With Stage IIB-IIIC Breast Cancer

University of Washington

Phase 2 Completed
68 enrolled 10 charts
Breast

Breast Neoplasms, Breast Neoplasms, Male, Inflammatory Breast Neoplasms

NCT00346229 2016-03-22

Temperature-Sensitive Liposomal Doxorubicin and Hyperthermia in Treating Women With Locally Recurrent Breast Cancer

Duke University

Phase 1 Terminated
29 enrolled
Breast

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00072319 2013-03-04

Neoadjuvant or Adjuvant Epirubicin, Cyclophosphamide, and Paclitaxel in Treating Women With Stage I, Stage II, or Stage III Breast Cancer

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
Breast

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00005800 2012-09-25

Doxorubicin and Docetaxel in Treating Women With Stage III Breast Cancer

H. Lee Moffitt Cancer Center and Research Institute

Phase 2 Completed
45 enrolled
Breast

Breast Neoplasms, Inflammatory Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡